Small-molecule Sb9 inhibitor targets both cancer and associated cells to suppress tumor growth in mice.

Biocatalysis is an increasingly attractive option in pharmaceutical synthesis.

Pharma hasn’t always covered itself in glory – but as the world scrambles for viable COVID-19 interventions, it has a rare opportunity to rebrand.

How can we get macromolecules across the intestinal epithelial barrier?

We Sit Down With Sandy Macrae, Chief Executive Officer, Sangamo Therapeutics, USA.

Vectura has more than 20 years’ experience in helping customers bring inhaled medicines to the market.

The increasing complexity of biologics raises significant manufacturing challenges – not least regarding cost control and downstream purification.

Patient perspectives can make a huge difference when designing drug delivery devices that are truly fit for real-world use.

Is the European Union better prepared for future healthcare crises?

With the right partner to help you harness the many benefits, nasal delivery is not to be sniffed at.